Short answer
Niagen Bioscience, Inc. (NAGE) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Earnings announcement covers the quarter ended March 31, 2026.
Niagen Bioscience, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings announcement covers the quarter ended March 31, 2026
- Press release attached as Exhibit 99.1 contains Niagen Bioscience’s financial results and management commentary
Item 7.01 · Regulation FD Disclosure
- Corporate presentation released May 6, 2026 under Regulation FD
- Exhibit 99.2 contains the investor-facing materials and may update strategy or business outlook
- Website availability broadens access to the company’s disclosed information
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Niagen Bioscience, Inc. 8-K filings
Get the next NAGE 8-K as it lands
Follow NAGE for push alerts, or ask the research agent what this filing means.